These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38944701)

  • 1. Association of Serum Homocysteine Level with Parkinson's Disease.
    Losy SA; Saiduzzman M; Battacharjee M; Moniruzzman AHM; Bhuya MSI; Linckon MK; Banerjee S; Islam MS; Mia E
    Mymensingh Med J; 2024 Jul; 33(3):643-648. PubMed ID: 38944701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease.
    Li J; Gu C; Zhu M; Li D; Chen L; Zhu X
    Psychogeriatrics; 2020 Mar; 20(2):180-188. PubMed ID: 31828903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease.
    Kirbas S; Kirbas A; Tufekci A; Cumhur Cure M; Cakmak S; Yazici T; Cure E
    Acta Clin Belg; 2016 Apr; 71(2):71-5. PubMed ID: 27075796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
    Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU
    West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum homocysteine and physical exercise in patients with Parkinson's disease.
    Nascimento CM; Stella F; Garlipp CR; Santos RF; Gobbi S; Gobbi LT
    Psychogeriatrics; 2011 Jun; 11(2):105-12. PubMed ID: 21707858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma levels of homocysteine in Parkinson's disease.
    Kuhn W; Roebroek R; Blom H; van Oppenraaij D; Przuntek H; Kretschmer A; Büttner T; Woitalla D; Müller T
    Eur Neurol; 1998 Nov; 40(4):225-7. PubMed ID: 9813406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease.
    Sleeman I; Lawson RA; Yarnall AJ; Duncan GW; Johnston F; Khoo TK; Burn DJ
    J Parkinsons Dis; 2019; 9(2):351-359. PubMed ID: 30909247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Homocysteine Level in Parkinson's Disease and Its Association with Duration, Cardinal Manifestation, and Severity of Disease.
    Saadat P; Ahmadi Ahangar A; Samaei SE; Firozjaie A; Abbaspour F; Khafri S; Khoddami A
    Parkinsons Dis; 2018; 2018():5813084. PubMed ID: 29854384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson's disease.
    Yang Y; Gao F; Gao L; Miao J
    BMC Neurol; 2023 Oct; 23(1):360. PubMed ID: 37803329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE CORRELATION BETWEEN SERUM HOMOCYSTEINE LEVEL AND PARKINSON'S DISEASE DISABILITY.
    Taher Y; Natheer M; Majdal H
    Georgian Med News; 2022 Oct; (331):36-41. PubMed ID: 36539128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between homocysteine and third ventricle dilatation, mesencephalic area atrophy in Parkinson's disease with cognitive impairment.
    Fu XY; Zhang YC; Ding CW; Yang M; Song X; Wang CS; Chen XF; Zhang Y; Sheng YJ; Mao P; Mao CJ; Liu CF
    J Clin Neurosci; 2021 Aug; 90():273-278. PubMed ID: 34275563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
    Xie Y; Feng H; Peng S; Xiao J; Zhang J
    Neurosci Lett; 2017 Jan; 636():190-195. PubMed ID: 27840145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Serum Homocysteine Levels Have Differential Gender-Specific Associations with Motor and Cognitive States in Parkinson's Disease.
    Bakeberg MC; Jefferson A; Riley M; Byrnes M; Ghosh S; Mastaglia FL; Horne MK; McGregor S; Stell R; Kenna J; Walters S; Hince D; Anderton RS
    Parkinsons Dis; 2019; 2019():3124295. PubMed ID: 31275543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions.
    Zoccolella S; Lamberti P; Iliceto G; Diroma C; Armenise E; Defazio G; Lamberti SV; Fraddosio A; de Mari M; Livrea P
    Clin Chem Lab Med; 2005; 43(10):1107-10. PubMed ID: 16197306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy.
    Todorović Z; Dzoljić E; Novaković I; Mirković D; Stojanović R; Nesić Z; Krajinović M; Prostran M; Kostić V
    J Neurol Sci; 2006 Oct; 248(1-2):56-61. PubMed ID: 16774768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of methylmalonate and homocysteine in Parkinson's disease, progressive supranuclear palsy and amyotrophic lateral sclerosis.
    Levin J; Bötzel K; Giese A; Vogeser M; Lorenzl S
    Dement Geriatr Cogn Disord; 2010; 29(6):553-9. PubMed ID: 20606437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and clinical effects of Whey protein supplementation in Parkinson's disease: A pilot study.
    Tosukhowong P; Boonla C; Dissayabutra T; Kaewwilai L; Muensri S; Chotipanich C; Joutsa J; Rinne J; Bhidayasiri R
    J Neurol Sci; 2016 Aug; 367():162-70. PubMed ID: 27423583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma homocysteine, folate and vitamin B12 levels in Parkinson's disease in China: A meta-analysis.
    Dong B; Wu R
    Clin Neurol Neurosurg; 2020 Jan; 188():105587. PubMed ID: 31733593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors.
    Sławek J; Roszmann A; Robowski P; Dubaniewicz M; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Kurzawski M; Bandurski T; Białecka M
    Neurodegener Dis; 2013; 12(1):1-12. PubMed ID: 22831964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.